Medtronic Inc (MDT-N) Profile - The Globe and Mail

Profile

Medtronic, Inc. acquired Ireland-based Covidien plc. The acquisition resulted in the formation of a new holding company incorporated in Ireland - Medtronic plc. The company currently generates revenues from four major segments - namely Cardiovascular Portfolio, Medical Surgical Portfolio, Neuroscience Portfolio and Diabetes. The Cardiovascular Portfolio, formerly reported as the Cardiac and Vascular Group, includes the Cardiac Rhythm & Heart Failure, Structural Heart & Aortic and Coronary & Peripheral Vascular divisions. The Medical Surgical Portfolio, formerly reported as the Minimally Invasive Therapies Group, includes the Surgical Innovations and the Respiratory, Gastrointestinal & Renal divisions. Neuroscience consists of Cranial & Spinal Technologies, Specialty The Neuroscience Portfolio, formerly reported as the Restorative Therapies Group, includes the Cranial & Spinal Technologies, Specialty Therapies, and Neuromodulation divisions.

Key Executives

Name	Title
Geoffrey S. Martha	CEO/Chairman of the Board/Director
Skip Harry Kiil	Executive VP/President, Divisional
Michelle Quinn	Executive VP/General Counsel/Secretary
Michael Marinaro	Executive VP/President, Divisional/President, Geographical
Matthew R. Walter	Senior VP, Divisional
Thierry Pieton	CFO/Executive VP
Denise L. Blomquist	Chief Accounting Officer/Controller/Vice President
Kweli Thompson	Executive VP/President, Divisional